
Keywords: Ag; antigen; bnAb; broadly neutralizing anti-HIV Ig; CLL; chronic lymphocytic leukemia; EBV; Epstein Barr virus; GBM; glomerular basement membrane; GN; glomerulonephritis; GP; Goodpasture; GPS; GP syndrome; HC; heavy chain; HCDR3; heavy chain complementar